About this trial
There is evidence for the effectiveness and feasibility of the individual components of TIER-HF-PC, however there is a need to test how these individual components interact to allow the researchers to deliver TIER-HF-PC as a model of care in its totality. In the short term, this study will assess if TIER-HF-PC is beneficial for patients and caregivers.
Eligibility criteria
Qualifiers
21 years or older and
able to communicate in English or Chinese and
be of stage C or D heart failure, as defined by American College of Cardiology/American Heart Association (ACC/AHA) classification system and
have functional limitation of New York Heart Association (NYHA) functional status of at least 2 or more and
Disqualifiers
have cognitive impairment (e.g., dementia)
have severe, untreated, active mental illness (e.g., major depressive disorder)
have ventricular assist device implant.
have non-reversible hearing or visual loss or
Trial design
Treatments tested in this trial
- TIER-HF-PC
- Usual Care
Treatment groups
Sponsors and collaborators
National Cancer Centre, Singapore
Lead sponsor
National Heart Centre Singapore
Collaborator
Khoo Teck Puat Hospital
Collaborator